Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

March 15, 2022; Volume 19,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. An, Liwei

    1. You have access
      Decoding the intercellular communication network during tumorigenesis
      Liwei An, Ruixian Yu, Yi Han and Zhaocai Zhou
      Cancer Biology & Medicine March 2022, 19 (3) 265-272; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0558
  2. Arghiani, Nahid

    1. You have access
      Modulating microRNAs in cancer: next-generation therapies
      Nahid Arghiani and Khalid Shah
      Cancer Biology & Medicine March 2022, 19 (3) 289-304; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0294
  3. Ba, Yi

    1. You have access
      Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
      Ming Bai, Meng Wang, Ting Deng, Yuxian Bai, Kai Zang, Zhanhui Miao, Wenlin Gai, Liangzhi Xie and Yi Ba
      Cancer Biology & Medicine March 2022, 19 (3) 358-369; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0388
  4. Bai, Ming

    1. You have access
      Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
      Ming Bai, Meng Wang, Ting Deng, Yuxian Bai, Kai Zang, Zhanhui Miao, Wenlin Gai, Liangzhi Xie and Yi Ba
      Cancer Biology & Medicine March 2022, 19 (3) 358-369; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0388
  5. Bai, Yuxian

    1. You have access
      Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
      Ming Bai, Meng Wang, Ting Deng, Yuxian Bai, Kai Zang, Zhanhui Miao, Wenlin Gai, Liangzhi Xie and Yi Ba
      Cancer Biology & Medicine March 2022, 19 (3) 358-369; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0388
  6. Bi, Jinghao

    1. You have access
      Dietary fat intake and liver cancer risk: A prospective cohort study in Chinese women
      Xiaowei Ji, Jing Wang, Zhuoying Li, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Yuting Tan, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine March 2022, 19 (3) 370-383; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0633
  7. Chen, Lei

    1. You have access
      The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
      Kaiting Wang, Xinyao Qiu, Yan Zhao, Hongyang Wang and Lei Chen
      Cancer Biology & Medicine March 2022, 19 (3) 305-318; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0306
  8. Chen, Tianqi

    1. You have access
      The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma
      Hua Ye, Tianqi Chen, Zhancheng Zeng, Bo He, Qianqian Yang, Qi Pan, Yueqin Chen and Wentao Wang
      Cancer Biology & Medicine March 2022, 19 (3) 343-357; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0661
  9. Chen, Yueqin

    1. You have access
      The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma
      Hua Ye, Tianqi Chen, Zhancheng Zeng, Bo He, Qianqian Yang, Qi Pan, Yueqin Chen and Wentao Wang
      Cancer Biology & Medicine March 2022, 19 (3) 343-357; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0661
  10. Cui, Jiuwei

    1. You have access
      Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome
      Hanfei Guo, Lei Qian and Jiuwei Cui
      Cancer Biology & Medicine March 2022, 19 (3) 333-342; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0087
« Previous (Pages : 1 2 3 4 5 6 ... 6) Next »
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (3)
Cancer Biology & Medicine
Vol. 19, Issue 3
15 Mar 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire